Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peggy Gao

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Journal of Diabetes Science and Technology|June 13, 2022
Comparisons of Fifth-, Sixth-, and Seventh-Generation Continuous Glucose Monitoring SystemsJohn B Welsh, Simon Psavko, Xiaohe Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|May 29, 2015
Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND StudiesTali Cukierman-Yaffe, Craig Anderson, Koon Teo, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 29, 2012
Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studiesIrene Marzona, Martin O'Donnell, Koon Teo, et al.
The Canadian Journal of Cardiology|October 11, 2011
The cost of clopidogrel use in atrial fibrillation in the ACTIVE-A trialAndre Lamy, Wesley Tong, Peggy Gao, et al.
Circulation. Cardiovascular Quality and Outcomes|July 13, 2012
Comparison of risk factor reduction and tolerability of a full-dose polypill (with potassium) versus low-dose polypill (polycap) in individuals at high risk of cardiovascular diseases: the Second Indian Polycap Study (TIPS-2) investigatorsSalim Yusuf, Prem Pais, Alben Sigamani, et al.
Heart (British Cardiac Society)|May 31, 2023
Fixed dose combination therapies in primary cardiovascular disease prevention in different groups: an individual participant meta-analysisGilles R Dagenais, Prem Pais, Peggy Gao, et al.
Circulation. Arrhythmia and Electrophysiology|November 8, 2014
Interaction between digoxin and dronedarone in the PALLAS trialStefan H Hohnloser, Jonathan L Halperin, A John Camm, et al.
Diabetes Technology & Therapeutics|January 26, 2019
Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring SystemsJohn B Welsh, Peggy Gao, Mark Derdzinski, et al.
Circulation. Cardiovascular Interventions|April 16, 2015
Activated clotting time and outcomes during percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction: insights from the FUTURA/OASIS-8 TrialGregory Ducrocq, Sanjit Jolly, Shamir R Mehta, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 21, 2013
Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCENDEva M Lonn, Sherryn Rambihar, Peggy Gao, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Journal of Diabetes Science and Technology|June 13, 2022
Comparisons of Fifth-, Sixth-, and Seventh-Generation Continuous Glucose Monitoring SystemsJohn B Welsh, Simon Psavko, Xiaohe Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|May 29, 2015
Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND StudiesTali Cukierman-Yaffe, Craig Anderson, Koon Teo, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 29, 2012
Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studiesIrene Marzona, Martin O'Donnell, Koon Teo, et al.
The Canadian Journal of Cardiology|October 11, 2011
The cost of clopidogrel use in atrial fibrillation in the ACTIVE-A trialAndre Lamy, Wesley Tong, Peggy Gao, et al.
Circulation. Cardiovascular Quality and Outcomes|July 13, 2012
Comparison of risk factor reduction and tolerability of a full-dose polypill (with potassium) versus low-dose polypill (polycap) in individuals at high risk of cardiovascular diseases: the Second Indian Polycap Study (TIPS-2) investigatorsSalim Yusuf, Prem Pais, Alben Sigamani, et al.
Heart (British Cardiac Society)|May 31, 2023
Fixed dose combination therapies in primary cardiovascular disease prevention in different groups: an individual participant meta-analysisGilles R Dagenais, Prem Pais, Peggy Gao, et al.
Circulation. Arrhythmia and Electrophysiology|November 8, 2014
Interaction between digoxin and dronedarone in the PALLAS trialStefan H Hohnloser, Jonathan L Halperin, A John Camm, et al.
Diabetes Technology & Therapeutics|January 26, 2019
Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring SystemsJohn B Welsh, Peggy Gao, Mark Derdzinski, et al.
Circulation. Cardiovascular Interventions|April 16, 2015
Activated clotting time and outcomes during percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction: insights from the FUTURA/OASIS-8 TrialGregory Ducrocq, Sanjit Jolly, Shamir R Mehta, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 21, 2013
Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCENDEva M Lonn, Sherryn Rambihar, Peggy Gao, et al.
Pageof 9